Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Lymphoid
×
90 days
×
Clear all
Filters
3
NCT02684292
2026-02-18
MK-3475-204
Merck Sharp & Dohme LLC
Phase 3
Completed
304 enrolled
2 FDA
NCT03598608
2026-02-05
MK-4280-003
Merck Sharp & Dohme LLC
Phase 1/2
Completed
137 enrolled